Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Boehringer Ingelheim and Re-Vana Therapeutics, a U.S. and UK based developer of ocular therapeutics and drug delivery ...

This prevents overwatering, protects plants, and saves water. Fully Automated Irrigation, a real Time-Saver With IrriSense, lawn care practically takes care of itself.

VEGA-3 Phase 3 Study VEGA-3 is the second Phase 3 clinical trial evaluating the safety and efficacy of Phentolamine Ophthalmic Solution 0.75% in subjects with presbyopia.

VEGA-3 Phase 3 Study VEGA-3 is the second Phase 3 clinical trial evaluating the safety and efficacy of Phentolamine Ophthalmic Solution 0.75% in subjects with presbyopia.

Opus Genetics announced positive topline results from VEGA-3, its phase 3 trial evaluating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia. VEGA-3 is the second phase 3 clinical ...

Stuart Therapeutics Announces Initial Results of Phase III Clinical Trial for ST-100 (Vezocolmitide) Ophthalmic Solution, a Novel Dry Eye Disease Candidate ...

Many protea species face extinction because of pressures on their native habitats.

Crompton Secures Largest-ever Solar Pumps Order of Rs. 101 Crore from Maharashtra Energy Development Agency (MEDA), Reinforcing its Leadership in Sustainable Irrigation Solutions ...

The FDA has approved Tryptyr (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease.

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease ...